The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 12, 2007
Filed:
Jun. 10, 2004
Jean-christophe Carry, Saint Maur des Fosses, FR;
Gilles Doerflinger, Les Ulis, FR;
Arielle Genevois-borella, Thias, FR;
Michel Evers, La Queue en Brie, FR;
Alain Le Brun, Vigneux, FR;
Jean-paul Martin, Colombes, FR;
Pascal Desmazeau, Tigery, FR;
Serge Mignani, Chatenay-Malabry, FR;
Heinz-werner Kleemann, Bischofsheim, DE;
Jean-Christophe Carry, Saint Maur des Fosses, FR;
Gilles Doerflinger, Les Ulis, FR;
Arielle Genevois-Borella, Thias, FR;
Michel Evers, La Queue en Brie, FR;
Alain Le Brun, Vigneux, FR;
Jean-Paul Martin, Colombes, FR;
Pascal Desmazeau, Tigery, FR;
Serge Mignani, Chatenay-Malabry, FR;
Heinz-Werner Kleemann, Bischofsheim, DE;
Sanofi-Aventis Deutschland GmbH, Frankfurt, DE;
Abstract
The present invention discloses and claims compounds of formula I and their pharmaceutically acceptable salts, and methods of using said compounds of formula I, either alone or in combination with other medicaments, as antiarrhythmic medicaments with a cardioprotective component for prophylaxis or treatment of infarction, for the treatment of angina pectoris, and as inhibitors of pathophysiological processes associated with the development of ischemia-induced damage, in particular in the triggering of ischemia-induced cardiac arrhythmias and of heart failure. Pharmaceutical compositions comprising compounds of formula I or compounds of formula I in combination with one or more other medicaments and processes for the preparation of compounds of formula I are also disclosed and claimed.